Wasatch Advisors Inc Sangamo Therapeutics, Inc Transaction History
Wasatch Advisors Inc
- $19.9 Billion
- Q4 2024
A detailed history of Wasatch Advisors Inc transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Wasatch Advisors Inc holds 9,231,505 shares of SGMO stock, worth $9.88 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
9,231,505
Previous 19,442,368
52.52%
Holding current value
$9.88 Million
Previous $16.7 Million
43.68%
% of portfolio
0.05%
Previous 0.08%
Shares
31 transactions
Others Institutions Holding SGMO
# of Institutions
141Shares Held
60.4MCall Options Held
1.46MPut Options Held
1.84M-
Vanguard Group Inc Valley Forge, PA9.37MShares$10 Million0.0% of portfolio
-
State Street Corp Boston, MA5.02MShares$5.37 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.7MShares$5.03 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.08MShares$3.3 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.74MShares$2.93 Million0.0% of portfolio
About SANGAMO THERAPEUTICS, INC
- Ticker SGMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 156,552,992
- Market Cap $168M
- Description
- Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...